Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-European shares rally as ECB promises support

Thu, 16th Dec 2021 08:32

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* ECB dials back stimulus a notch

* Airbus wins aircraft deals from Qantas and Air France-KLM

* UK bank shares leap as BoE hikes rates

* Euro zone PMI data disappoints
(Updates to close)

By Anisha Sircar and Susan Mathew

Dec 16 (Reuters) - European shares had their best day in
more than a week on Thursday, led by gains in banks and miners
after the European Central Bank promised continued support to
the economy, still choosing to incrementally withdraw stimulus.

The pan-European STOXX 600 index rose 1.2%, while
the euro zone index closed up 0.9%.

The ECB only slightly reined in stimulus, as it strives for
sustainable economic growth, saying it would wind down its 1.85
trillion euro Pandemic Emergency Purchase Programme by March.

New data showed euro zone business growth slowed more than
expected in December as renewed measures to curb the Omicron
coronavirus variant curtailed recovery.

But the central bank plans to double bond buys to 40 billion
euros under the longer-running Asset Purchase Programme in the
second quarter before cutting them to 30 billion euros in the
third quarter.

"Despite a somewhat faster transition phase after PEPP ends,
the open ended nature of purchases should be seen as a sign that
the ECB is still significantly more dovish than its peers,"
Rabobank analysts said in a note.

"While the new inflation projections are significantly
higher, at 1.8% the medium-term forecasts still fall short of
the levels needed for sharper policy tightening."

The ECB decision came shortly after the Bank of England
became the first major central bank to raise borrowing costs
since the pandemic began, hiking rates to 0.25% from 0.1%.

That pushed Britain's benchmark bond yields
slightly higher to 0.75%. HSBC Holdings, Lloyds
and Barclay's jumped between 3.2% and 4.6% and
were among the top boosts on the FTSE 100 index.

On Wednesday, the U.S. Federal Reserve flagged a
long-awaited end to its pandemic-era bond purchases in March and
signalled as many as three rate hikes in 2022, but delivered an
otherwise upbeat economic outlook.

Oil and metal prices took heart, lifting energy stocks
and miners.

The healthcare sector was lifted by 5.7% surge in
Novartis AG after it launched a new share buyback of up
to $15 billion.

AstraZeneca gained 2.2% after saying a lab-study of
its COVID-19 antibody cocktail, Evusheld, found that the
treatment retained neutralising activity against the Omicron
coronavirus variant.

Airbus SE rose 2.4% after Australia's Qantas
Airways chose the planemaker as its preferred supplier for its
domestic fleet and Air France KLM struck a deal for
dozens of narrowbody jets.

French power giant EDF plunged 15.5% after it found
faults at a nuclear power station and shut down another plant
using the same kind of reactors.
(Reporting by Anisha Sircar and Shashank Nayar in Bengaluru;
Editing by Devika Syamnath, Krishna Chandra Eluri and Alison
Williams)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.